Abstract: The invention described herein provide a modified VPI capsid enabling preferential targeted expression of gene of interest (GOI) in muscle tissues, as well as recombinant adeno-associated virus (rAAV) with the GOI packaged with the modified VPI capsids, and uses thereof.